REG - Intelligent Ultrasnd - ScanNav FetalCheck Used in Trial Study

Intelligent UltrasoundAnnouncement

27/02/2024 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240227:nRSa6700Ea&default-theme=true

RNS Number : 6700E  Intelligent Ultrasound Group PLC  27 February 2024

Intelligent Ultrasound announces that its gestational age estimation AI
software, ScanNav FetalCheck, is being used in the largest ever trial study on
use of aspirin to prevent pre-eclampsia

 

PRESS RELEASE 27 February 2024: Intelligent Ultrasound Group plc (AIM: IUG),
the 'classroom to clinic' ultrasound company specialising in artificial
intelligence (AI) software and simulation, is pleased to announce that its
gestational age software, ScanNav FetalCheck, is to be used in the largest
ever trial on the use of aspirin to prevent pre-eclampsia.

 

Conducted in Kenya, Ghana and South Africa, the trial is funded by the Bill
& Melinda Gates Foundation and led by international NGO Concept
Foundation*. It will compare the effects of daily intake of two different
doses of aspirin during pregnancy: 75 mg and 150mg among pregnant women at
high risk of developing pre-eclampsia. It aims to advance evidence on
pre-eclampsia prevention and inform policies so that women who are treated
with aspirin to prevent pre-eclampsia receive a dose that is both effective
and safe.

 

Having an accurate gestational age is important in the prevention of
pre-eclampsia for two reasons. Firstly, the risk of the condition depends on a
number of clinical factors which change with gestational age. Secondly, the
prophylactic effect of aspirin depends on when it is first administered within
the pregnancy. However, accurate determination of fetal age is difficult in
LMICs as it must be measured by trained sonographers, and very few front-line
healthcare workers have the necessary skills.

 

The clinical trial sites conducting risk screening will use Intelligent
Ultrasound's ScanNav FetalCheck software to enable frontline healthcare
professionals, with no prior experience of ultrasound, to quickly estimate
gestational age.

 

The software uses artificial intelligence (AI) to estimate the gestational age
without requiring the sonographer to take precise biometry measurements. As
well as allowing any healthcare professional to make the measurement, the
technology also reduces equipment cost and speeds up the scan without
compromising accuracy. **

 

 

Nicholas Sleep, COO at Intelligent Ultrasound said:

"We are very pleased that a trial of this size is using ScanNav FetalCheck to
accurately measure gestational age as an important factor in the prevention on
pre-eclampsia. We see this as continued endorsement of our technology for
situations when scanning needs to be undertaken by healthcare professionals
with limited experience of ultrasound.

 

In the future, we aim to roll-out the technology in primary care settings in
both LMICs and in high income countries (HICs) by allowing the age of the
fetus to be assessed in a primary care setting where women need it. This will
not only help reduce the incidence of pre-eclampsia but can also improve the
management of other pregnancy-related conditions that affect mother and
fetus."

 

* The project is conducted in collaboration between Concept Foundation, Burnet
Institute, University of Ghana, University of Nairobi, University of Cape
Town, Nossal Institute for Global Health  - University of Melbourne, Tommy's
National Centre for Maternity Improvement, and Intelligent Ultrasound, with
the generous financial support of Bill & Melinda Gates Foundation.

 

** ScanNav FetalCheck is currently not licenced for clinical use. Validation
studies in progress.

 

ENDS

 

Enquiries:

 

 Intelligent Ultrasound Group plc   www.intelligentultrasound.com (http://www.intelligentultrasound.com)
 Stuart Gall, CEO                   Tel: +44 (0)29 2075 6534
 Helen Jones, CFO

 Cavendish Capital Markets Limited

 (Nominated advisor and broker)
 Giles Balleny (Corporate Finance)  Tel: +44 (0)20 7397 8900

 Nigel Birks (ECM)

 Dale Bellis (Sales)

 

  TB Cardew - PR Advisors   Intelligentultrasound@tbcardew.com (mailto:Intelligentultrasound@tbcardew.com)

  Ed Orlebar                          Tel: +44 (0)7738 724630
  Allison Connolly                                                    Tel: +44 (0)7587 453955
  Emma Pascoe-Watson                                                  Tel: +44 (0)7774 620415
  Jessica Pilling                                                     Tel: +44 (0)7918 584573

 

 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to
clinic' ultrasound companies, specialising in real-time hi-fidelity virtual
reality simulation for the ultrasound training market ('classroom') and
artificial intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market ('clinic'). Based in Cardiff in
the UK and Atlanta in the US, the Group has two revenue streams:

 

Simulation

Real-time hi-fidelity ultrasound education and training through simulation.
Our main products are the ScanTrainer obstetrics and gynaecology training
simulator, the HeartWorks echocardiography training simulator,
the BodyWorks Eve Point of Care and Emergency Medicine training simulator
with Covid-19 module and the new BabyWorks Neonate and Paediatric training
simulator. To date over 1,500 simulators have been sold to over 750 medical
institutions around the world.

 

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more
accessible using our proprietary ScanNav ultrasound image analysis technology.
Current products on the market utilising this technology are GE
HealthCare's SonoLyst software that is incorporated in their Voluson Expert
22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer
that teaches real-time ultrasound-guided needling and incorporates ScanNav
Anatomy PNB.

 

www.intelligentultrasound.com (http://www.intelligentultrasound.com/)

 

NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in the US by the
FDA, but is not available for sale in any other territory requiring government
approval for this type of product.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPUGCPUPCGAM